Cargando…
Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways
BACKGROUND: Thymic carcinomas (TCs) and thymic neuroendocrine neoplasms (TNENs) are two aggressive subtypes of thymic malignancy. Traditional therapy for advanced TCs and TNENs has limited outcome. New genomic profiling of TCs and TNENs might provide insights that contribute to the development of ne...
Autores principales: | Wang, Shuyuan, Gu, Zhitao, Zhu, Lei, Han, Yuchen, Yu, Hong, Fang, Wentao, Han, Baohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684125/ https://www.ncbi.nlm.nih.gov/pubmed/37749819 http://dx.doi.org/10.1097/CM9.0000000000002852 |
Ejemplares similares
-
Deciphering tissue‐based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors
por: Ku, Xin, et al.
Publicado: (2020) -
The combination of etoposide and platinum for the treatment of thymic neuroendocrine neoplasms: A retrospective analysis
por: Guan, Yelan, et al.
Publicado: (2023) -
AB005. Thymic carcinoma arising in a multilocular thymic cyst that previously went through complete remission after antibiotics treatment
por: Yu, Fenghao, et al.
Publicado: (2022) -
On the staging of thymic epithelial neoplasms
por: Suster, David, et al.
Publicado: (2019) -
Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors
por: Ahn, Soomin, et al.
Publicado: (2012)